T. Rowe Price Health Sciences Fund, Inc.'s T. Rowe Price Health Sciences Fund, Inc. (PRHSX) has disclosed 136 total holdings in their latest N-PORT filing with the SEC for the
portfolio date of 2024-03-31. The current portfolio value is calculated to be $13.86 Bil, only including common equities, preferred
equities, ETFs, options and warrants for equities. The turnover rate is 11%.
T. Rowe Price Health Sciences Fund, Inc. (PRHSX)'s
Total Assets is $15.45 Bil , Total Liabilities is $41.11 Mil , Net Assets is $15.41 Bil.
In T. Rowe Price Health Sciences Fund, Inc. (PRHSX)'s current portfolio as of 2024-03-31, the top 5 holdings are
Eli Lilly and Co (LLY), UnitedHealth Group Inc (UNH), Intuitive Surgical Inc (ISRG), Thermo Fisher Scientific Inc (TMO) and Merck & Co Inc (MRK),
not including call and put options.
T. Rowe Price Health Sciences Fund, Inc. (PRHSX) did not buy any new stocks in the current portfolio.
Please visit the "Current Portfolio" tab to see the mutual fund's current and past N-PORT holdings for T. Rowe Price Health Sciences Fund, Inc. (PRHSX), as well as holding map,
valuations for each stock, which positions are undervalued, have low PE Ratios, are considered high quality and recently traded at 52-week lows, etc.
Please visit the "Stock Picks" tab to see the mutual fund's latest trades and stock picks for T. Rowe Price Health Sciences Fund, Inc. (PRHSX), which include data from form N-PORT.
Please visit the "Summary" page to see the top 10 holdings, recent stock picks, performance, sector / industry breakdown details, as well as past holding history summary for T. Rowe Price Health Sciences Fund, Inc..